Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells

Authors:
  • LBLuca Busino
    Luca Busino
  • IBIrene De Biase
    Irene De Biase
  • MCMaria S. Lo Casale
    Maria S. Lo Casale
  • PGPaola Giuliano
    Paola Giuliano
  • AMAntonella Monticelli
    Antonella Monticelli
  • MTMimmo Turano
    Mimmo Turano
  • CCChiara Criscuolo
    Chiara Criscuolo
  • AFAlessandro Filla
    Alessandro Filla
  • SVStelio Varrone
    Stelio Varrone
  • SCSergio Cocozza
    Sergio Cocozza

Abstract
The severe reduction in mRNA and protein levels of the mitochondrial protein frataxin, encoded by the X25 gene, causes Friedreich ataxia (FRDA), the most common form of recessive hereditary ataxia. Increasing evidence underlines the pathogenetic role of oxidative stress in this disease. We generated an in vitro cellular model of regulated human frataxin overexpression. We identified, by differential display technique, the mitogen activated protein kinase kinase 4 mRNA down regulation in frataxin overexpressing cells. We studied the stress kinases pathway in this cellular model and in fibroblasts from FRDA patients. Frataxin overexpression reduced c-Jun N-terminal kinase phosphorylation. Furthermore, exposure of FRDA fibroblasts to several forms of environmental stress caused an up regulation of phospho-JNK and phospho-c-Jun. To understand if this susceptibility results in cell death, we have investigated the involvement of caspases. A significantly higher activation of caspase-9 was observed in FRDA versus control fibroblasts after serum-withdrawal. Our findings suggest the presence, in FRDA patient cells, of a ‘hyperactive’ stress signaling pathway. The role of frataxin in FRDA pathogenesis could be explained, at least in part, by this hyperactivity.